A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2011
11/16/2011	CN101468194B Medicine composition for treating colitis and method of making the same
11/16/2011	CN101461859B Method for controlling quality of anti-inflammation antibacterial medicament
11/16/2011	CN101461829B Spikemoss extract, extraction method and application thereof
11/16/2011	CN101395168B Galactose derivative,Drug carrier and medicinal composition
11/16/2011	CN101357144B Selaginella uncinata extraction, its preparation method and application
11/16/2011	CN101336955B Gynostemma pentaphylla extract and preparation method thereof and use thereof in preparing medicine for preventing and treating fatty liver and sub-health
11/16/2011	CN101204582B Multivalent hepatitis B fusion protein targeted adjuvant vaccine, preparation method and uses thereof
11/16/2011	CN101011450B Quality control method for lucid ganoderma gynostemma pentaphylla oral liquid
11/16/2011	CN101011445B Quality control method for cactus stomach health-care capsule
11/16/2011	CN100998788B Traditional Chinese medicine composition dripping for treating gastrointestinal disease and its preparing method
11/15/2011	US8058426 Phosphorus-containing compounds and uses thereof
11/15/2011	US8058344 Glycodendrimers having biological activity
11/15/2011	US8058289 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
11/15/2011	US8058282 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
11/15/2011	US8058280 Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof
11/15/2011	US8058277 Substituted indoles
11/15/2011	US8058267 Steroids as agonists for FXR
11/15/2011	US8058249 Immunostimulatory nucleic acid molecules
11/15/2011	CA2479126C Combination treatments for chemokine-mediated diseases
11/15/2011	CA2469612C Treatment of statin side effects using uridine derivatives
11/15/2011	CA2449403C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/15/2011	CA2385736C Mediators of hedgehog signaling pathways, compositions and uses related thereto
11/15/2011	CA2352537C Tgf.beta.1-inhibitor peptides
11/10/2011	WO2011140429A1 Delivery of cholesteryl ester to steroidogenic tissues
11/10/2011	WO2011139763A1 Methods and compositions for inducing satiety
11/10/2011	WO2011139237A1 Composition for the treatment of helicobacter pylori (h. pylori) infectious
11/10/2011	WO2011139118A2 A pharmaceutical composition and a health functional food composition for preventing, treating or improving a gastrointestinal dyskinetic disease
11/10/2011	WO2011138916A1 Polycyclic compound
11/10/2011	WO2011110854A3 The use of amisulpride as an anti-emetic
11/10/2011	WO2011088075A3 Novel salts, polymorphs, and synthetic processes regarding imidazole derivative
11/10/2011	WO2011087835A3 Novel compositions and methods for treating inflammatory bowel disease and airway inflammation
11/10/2011	WO2011084781A3 Oral care compositions and methods
11/10/2011	US20110275684 Novel benzotriazole derivatives useful for the treatment of cns disorders
11/10/2011	US20110275682 Novel choline cocrystal of epalrestat
11/10/2011	US20110275680 Noxel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
11/10/2011	US20110275678 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics
11/10/2011	US20110275671 Dihydroindolinone derivatives
11/10/2011	US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011	US20110275667 Compositions useful for treating gastroesophageal reflux disease
11/10/2011	US20110275656 3H-Imidazo [4, 5-C] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
11/10/2011	US20110275655 Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
11/10/2011	US20110275639 C5aR ANTAGONISTS
11/10/2011	US20110275637 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011	US20110275636 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
11/10/2011	US20110275629 Pyridazino-pyridinone Compounds and Methods of Use
11/10/2011	US20110275628 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
11/10/2011	US20110275626 Formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules
11/10/2011	US20110275611 Chemical compounds
11/10/2011	US20110275607 Nuclear transport modulators and uses thereof
11/10/2011	US20110275603 Novel immunomodulator and anti-inflammatory compounds
11/10/2011	US20110275574 Method of inhibiting proliferation of hepatic stellate cells
11/10/2011	US20110275568 Methods of enhancing functioning of the large intestine
11/10/2011	US20110275566 Methods of treating necrotizing enterocolitis using heparin binding epidermal growth factor (hb-egf)
11/10/2011	US20110275555 Compositions containing delta-9-thc-amino acid esters and process of preparation
11/10/2011	US20110274771 Prenatal Syptomatic Kit
11/10/2011	US20110274765 Flavored colonic cleansing system
11/10/2011	US20110274764 Flavored colonic cleansing system
11/10/2011	US20110274754 Oral tablet compositions of dexlansoprazole
11/10/2011	US20110274753 Dual release oral tablet compositions of dexlansoprazole
11/10/2011	US20110274752 Modified release pharmaceutical compositions of dexlansoprazole
11/10/2011	US20110274738 Functionalized chemically inert polymers for coatings
11/10/2011	US20110274728 Compositions and Methods for Alleviating Hyposalivation and for Providing Oral Comfort
11/10/2011	US20110274722 Food containing a probiotic and an isolated beta-glucan and methods of use thereof
11/10/2011	US20110274717 POLYSACCHARIDE CONJUGATION WITH DETOXIFIED E. coli HEAT LABILE ENTEROTOXIN (LT) USED AS VACCINE
11/10/2011	US20110274716 Compositions containing fucoxanthin extract
11/10/2011	US20110274704 Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
11/10/2011	US20110274703 Detection and treatment of non-dermal fibrosis
11/10/2011	US20110274699 ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
11/10/2011	US20110274698 Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto
11/10/2011	US20110274696 Antibodies to ccr2
11/10/2011	US20110274670 Mesenchymal stem cells which express human hepatic growth factor,manufacturing method thereof, and use thereof as therapeutic agent for liver diseases
11/10/2011	US20110274664 Hepatic progenitor cells and uses thereof
11/10/2011	US20110274655 Tetrazolones as inhibitors of fatty acid synthase
11/10/2011	US20110274653 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/10/2011	US20110274623 Stabilized Fibronectin Domain Compositions, Methods and Uses
11/10/2011	US20110274616 4-(2,6-dichloro-benzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
11/09/2011	EP2385064A2 Agents disrupting a growth factor complex
11/09/2011	EP2385063A2 Growth factor complex
11/09/2011	EP2385042A1 Prokineticin 1 receptor antagonists
11/09/2011	EP2385032A1 GPR40 Receptor function regulator
11/09/2011	EP2384791A2 Method and composition for treating mucosal disorders
11/09/2011	EP2384790A2 Method and composition for treating mucosal disorders
11/09/2011	EP2384747A2 Oral Tablet Compositions Of Dexlansoprazole
11/09/2011	EP2384746A2 Dual release oral tablet compositions of dexlansoprazole
11/09/2011	EP2384745A2 Modified Release Pharmaceutical Compositions Of Dexlansoprazole
11/09/2011	EP2384740A2 Oral care product and methods of use and manufacture thereof
11/09/2011	EP2384739A2 Oral care product and methods of use and manufacture thereof
11/09/2011	EP1982721B1 Method of stabilizing s-adenosyl-l-methionine and stabilized composition
11/09/2011	EP1669450B1 Staple type oligonucleotide and drug comprising the same
11/09/2011	EP1328624B1 B7-like molecules and uses thereof
11/09/2011	EP1313769B2 Antibodies to human il-1 beta
11/09/2011	CN1931232B Oil-in-water nanometer perilla seed oil emulsion oral liquid and its preparation process
11/09/2011	CN1248288B Nuclear transfer with differentiated fetal and adult donor cells
11/09/2011	CN102239167A Imidazopyridine derivatives which inhibit the secretion of gastric acid
11/09/2011	CN102239164A 2h-chromene compound and derivative thereof
11/09/2011	CN102239159A 7-piperidinoalkyl-3,4-dihydroquinolone derivative
11/09/2011	CN102239136A Casr agonist
11/09/2011	CN102234687A Application of micro ribose nucleic acid (miRNA) or precursor thereof of inhibitor zinc finger protein Zinc finger and BTBdomain-containing protein 20 (ZBTB20)
11/09/2011	CN102234626A Hepatic progenitor cells and uses thereof
11/09/2011	CN102234622A Lactobacillus fermentum SG-A95 for improving bacterial populations in oral cavity and health-care composition thereof

1 ... 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 ... 1258